Home Tags Pablo J. Cagnoni

Tag: Pablo J. Cagnoni

RUBIUS THERAPEUTICS spent $163.5 million in 2019. The company does not yet generate revenue.

Rubius Therapeutics reports $163.5M loss in 2019; focuses on oncology and...

PROVIDENCE – Rubius Therapeutics Inc. reported a year-end loss of $163.5 million in 2019, an increase from $89.2 million in 2018. Loss per diluted share...
RUBIUS THERAPEUTICS reported a loss of $39.4 million in the second quarter of 2019. The company has yet to record revenue..4 million in the second quarter of 2019, The company is yet to have revenue.

Rubius reports $39.4M loss in Q2, heralds progress

PROVIDENCE – Rubius Therapeutics Inc. reported on Tuesday a loss of $39.4 million in the second quarter of 2019, or 50 cents per diluted...
RUBIUS THERAPEUTICS reported a $32.6 million loss in the first quarter of 2019.

Rubius Therapeutics reports $32.6M loss in Q1

SMITHFIELD – Rubius Therapeutics Inc. reported a net loss of $32.6 million in the first quarter of 2019, or 42 cents per diluted share,...
RUBIUS THERAPEUTICS reported a $26.4 million loss for the third quarter. The company does not yet generate revenue.

Rubius reports $26.4M loss for Q3

PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...

Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News